Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: A randomised, phase 2 cohort of the open-label KEYNOTE-021 study - Langer, C J; Gadgeel, S M; Borghaei, H (The Lancet Oncology, 2016)
et al.